Mark Kaddumukasa1, Jane Nakibuuka2, Levicatus Mugenyi2, Olivia Namusoke2, Doreen Birungi2, Bryan Kabaala2, Carol Blixen3, Elly Katabira4, Anthony Furlan5, Martha Sajatovic6. 1. Department of Medicine, School of Medicine, Makerere University College of Health Sciences, P.O. Box 7072, Kampala, Uganda. Electronic address: mkaddumukasa@chs.mak.ac.ug. 2. Department of Medicine, School of Medicine, Makerere University College of Health Sciences, P.O. Box 7072, Kampala, Uganda. 3. Department of Neurology, Case Western Reserve University School of Medicine, University Hospitals Cleveland Medical Center, 11100 Euclid Avenue, Cleveland, OH 44106, USA. Electronic address: cxb28@case.edu. 4. Department of Medicine, School of Medicine, Makerere University College of Health Sciences, P.O. Box 7072, Kampala, Uganda. Electronic address: katabira@imul.com. 5. Department of Neurology, Case Western Reserve University School of Medicine, University Hospitals Cleveland Medical Center, 11100 Euclid Avenue, Cleveland, OH 44106, USA. Electronic address: Anthony.furlan@uhhospitals.org. 6. Department of Neurology, Department of Psychiatry, Case Western Reserve University School of Medicine, Neurological and Behavioral Outcomes Center, University Hospitals Cleveland Medical Center, 11100 Euclid Avenue, Cleveland, OH 44106, USA. Electronic address: Martha.Sajatovic@UHhospitals.org.
Abstract
INTRODUCTION: Stroke remains a global concern due to increasing lifespan, patterns of industrialization, adoption of harmful western diets, and an increasing prevalence of risk factors such as hypertension, obesity, and diabetes. We investigated an adopted novel self-management intervention, TargetEd mAnageMent Intervention (TEAM) to reduce modifiable stroke risk factors in Uganda. METHODS: A six-month, uncontrolled, prospective pilot study to establish feasibility, acceptability and preliminary efficacy of TEAM in Ugandans at high risk for stroke was conducted. The primary outcome was change in systolic BP from baseline to 24-week follow-up. Secondary outcomes included change in diastolic BP, serum cholesterol, high and low density lipoprotein (HDL, LDL) and triglycerides. RESULTS: Mean (SD) baseline systolic BP was 162.9 (±25.6) mmHg while mean (SD) baseline diastolic BP was 99.1 (±13.8) mmHg. There was a significant reduction in mean baseline blood pressure of 163/98.8mmHg to blood pressure of 147.8/88.0mmHg at 24weeks, P=0.023. There were also significant reductions in the serum total cholesterol levels at 24weeks with P=0.001. CONCLUSION: Targeted training in self-management (TEAM) adapted to the Ugandan setting is feasible, highly acceptable to participants and appears to be associated with reduced blood pressure, improved lipid profiles and improved glucose control in diabetics.
INTRODUCTION:Stroke remains a global concern due to increasing lifespan, patterns of industrialization, adoption of harmful western diets, and an increasing prevalence of risk factors such as hypertension, obesity, and diabetes. We investigated an adopted novel self-management intervention, TargetEd mAnageMent Intervention (TEAM) to reduce modifiable stroke risk factors in Uganda. METHODS: A six-month, uncontrolled, prospective pilot study to establish feasibility, acceptability and preliminary efficacy of TEAM in Ugandans at high risk for stroke was conducted. The primary outcome was change in systolic BP from baseline to 24-week follow-up. Secondary outcomes included change in diastolic BP, serum cholesterol, high and low density lipoprotein (HDL, LDL) and triglycerides. RESULTS: Mean (SD) baseline systolic BP was 162.9 (±25.6) mmHg while mean (SD) baseline diastolic BP was 99.1 (±13.8) mmHg. There was a significant reduction in mean baseline blood pressure of 163/98.8mmHg to blood pressure of 147.8/88.0mmHg at 24weeks, P=0.023. There were also significant reductions in the serum total cholesterol levels at 24weeks with P=0.001. CONCLUSION: Targeted training in self-management (TEAM) adapted to the Ugandan setting is feasible, highly acceptable to participants and appears to be associated with reduced blood pressure, improved lipid profiles and improved glucose control in diabetics.
Authors: Leopold Fezeu; Etienne Minkoulou; Beverley Balkau; André-Pascal Kengne; Paschal Awah; Nigel Unwin; George K M M Alberti; Jean-Claude Mbanya Journal: Int J Epidemiol Date: 2005-10-28 Impact factor: 7.196
Authors: George Howard; Daniel T Lackland; Dawn O Kleindorfer; Brett M Kissela; Claudia S Moy; Suzanne E Judd; Monika M Safford; Mary Cushman; Stephen P Glasser; Virginia J Howard Journal: JAMA Intern Med Date: 2013-01-14 Impact factor: 21.873
Authors: Valery L Feigin; Mohammad H Forouzanfar; Rita Krishnamurthi; George A Mensah; Myles Connor; Derrick A Bennett; Andrew E Moran; Ralph L Sacco; Laurie Anderson; Thomas Truelsen; Martin O'Donnell; Narayanaswamy Venketasubramanian; Suzanne Barker-Collo; Carlene M M Lawes; Wenzhi Wang; Yukito Shinohara; Emma Witt; Majid Ezzati; Mohsen Naghavi; Christopher Murray Journal: Lancet Date: 2014-01-18 Impact factor: 79.321
Authors: Margaret Thorogood; Myles Connor; Stephen Tollman; Gillian Lewando Hundt; Gerry Fowkes; Jennifer Marsh Journal: BMC Public Health Date: 2007-11-13 Impact factor: 3.295
Authors: David Guwatudde; Gerald Mutungi; Ronald Wesonga; Richard Kajjura; Hafisa Kasule; James Muwonge; Vincent Ssenono; Silver K Bahendeka Journal: PLoS One Date: 2015-09-25 Impact factor: 3.240
Authors: Bethany M Kwan; L Miriam Dickinson; Russell E Glasgow; Martha Sajatovic; Mark Gritz; Jodi Summers Holtrop; Don E Nease; Natalie Ritchie; Andrea Nederveld; Dennis Gurfinkel; Jeanette A Waxmonsky Journal: Trials Date: 2020-01-10 Impact factor: 2.728